Ascend Wellness Holdings (AAWH) Cash & Current Investments (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Cash & Current Investments of $60.9 million in Q1 2026, down 28.89% quarter-over-quarter from $85.7 million in Q4 2025, and down 39.1% on a YoY basis from $100.0 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Cash & Current Investments (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $60.9 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 39.1% year-over-year to $60.9 million; the TTM figure through Mar 2026 stood at $60.9 million (down 39.1% YoY), while the FY2025 annual figure was $85.7 million, down 2.92% from the prior year.
- Cash & Current Investments was $60.9 million for Q1 2026 at Ascend Wellness Holdings, down from $85.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $143.8 million in Q1 2022 to a low of $60.9 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $86.3 million across 5 years, with a median of $83.7 million in 2024.
- Biggest YoY gain for Cash & Current Investments was 22159.6% in 2022; the steepest drop was 55.31% in 2022.
- A 5-year view of Cash & Current Investments shows it stood at $74.1 million in 2022, then slipped by 2.21% to $72.5 million in 2023, then advanced by 21.72% to $88.3 million in 2024, then retreated by 2.92% to $85.7 million in 2025, then slipped by 28.89% to $60.9 million in 2026.
- The last three Cash & Current Investments figures came in at $60.9 million (Q1 2026), $85.7 million (Q4 2025), and $87.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 60.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.92 Mn |
| Dec 31, 2025 | 85.68 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Jun 30, 2025 | 95.27 Mn |
| Mar 31, 2025 | 100.03 Mn |
| Dec 31, 2024 | 88.25 Mn |
| Sep 30, 2024 | 65.28 Mn |
| Jun 30, 2024 | 83.71 Mn |
| Mar 31, 2024 | 72.90 Mn |
| Dec 31, 2023 | 72.51 Mn |
| Sep 30, 2023 | 63.92 Mn |
| Jun 30, 2023 | 68.05 Mn |
| Mar 31, 2023 | 73.30 Mn |
| Dec 31, 2022 | 74.15 Mn |
| Sep 30, 2022 | 91.39 Mn |
| Jun 30, 2022 | 140.55 Mn |
| Mar 31, 2022 | 143.80 Mn |
| Dec 31, 2021 | 155.48 Mn |
| Sep 30, 2021 | 204.51 Mn |
| Mar 31, 2021 | 646,000.00 |